My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 339

    1.

    Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study.

    Vergis EN, Hayden MK, Chow JW, Snydman DR, Zervos MJ, Linden PK, Wagener MM, Schmitt B, Muder RR.

    Ann Intern Med. 2001 Oct 2;135(7):484-92.PMID: 11578151 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.

    Ghanem G, Hachem R, Jiang Y, Chemaly RF, Raad I.

    Infect Control Hosp Epidemiol. 2007 Sep;28(9):1054-9. Epub 2007 Jul 12.PMID: 17932826 [PubMed - indexed for MEDLINE]Related articles

    3.

    A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.

    Bhavnani SM, Drake JA, Forrest A, Deinhart JA, Jones RN, Biedenbach DJ, Ballow CH.

    Diagn Microbiol Infect Dis. 2000 Mar;36(3):145-58.PMID: 10729656 [PubMed - indexed for MEDLINE]Related articles

    4.

    Determinants of vancomycin resistance and death in enterococcal bacteremia.

    [No authors listed]

    Ann Intern Med. 2001 Oct 2;135(7):S-43. No abstract available. PMID: 11596573 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.

    Chou YY, Lin TY, Lin JC, Wang NC, Peng MY, Chang FY.

    J Microbiol Immunol Infect. 2008 Apr;41(2):124-9.PMID: 18473099 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome.

    Han SH, Chin BS, Lee HS, Jeong SJ, Choi HK, Kim CO, Yong D, Choi JY, Song YG, Lee K, Kim JM.

    J Infect. 2009 Mar;58(3):182-90. Epub 2009 Feb 23.PMID: 19233476 [PubMed - indexed for MEDLINE]Related articles

    7.

    Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality? The Johns Hopkins SICU Study Group.

    Mainous MR, Lipsett PA, O'Brien M.

    Arch Surg. 1997 Jan;132(1):76-81.PMID: 9006556 [PubMed - indexed for MEDLINE]Related articles

    8.

    Epidemiological, microbiological, clinical, and prognostic factors of bacteremia caused by high-level vancomycin-resistant Enterococcus species.

    Peset V, Tallón P, Sola C, Sánchez E, Sarrión A, Pérez-Bellés C, Vindel A, Cantón E, Gobernado M.

    Eur J Clin Microbiol Infect Dis. 2000 Oct;19(10):742-9.PMID: 11117637 [PubMed - indexed for MEDLINE]Related articles

    9.

    Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center.

    Lodise TP, McKinnon PS, Tam VH, Rybak MJ.

    Clin Infect Dis. 2002 Apr 1;34(7):922-9. Epub 2002 Mar 4.PMID: 11880957 [PubMed - indexed for MEDLINE]Related articles

    10.

    Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.

    Linden PK, Pasculle AW, Manez R, Kramer DJ, Fung JJ, Pinna AD, Kusne S.

    Clin Infect Dis. 1996 Apr;22(4):663-70.PMID: 8729206 [PubMed - indexed for MEDLINE]Related articles

    11.

    Systemic inflammatory response syndrome in nosocomial bloodstream infections with Pseudomonas aeruginosa and Enterococcus Species: comparison of elderly and nonelderly patients.

    Marra AR, Bar K, Bearman GM, Wenzel RP, Edmond MB.

    J Am Geriatr Soc. 2006 May;54(5):804-8.PMID: 16696747 [PubMed - indexed for MEDLINE]Related articles

    12.

    Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection.

    DiazGranados CA, Jernigan JA.

    J Infect Dis. 2005 Feb 15;191(4):588-95. Epub 2005 Jan 17.PMID: 15655783 [PubMed - indexed for MEDLINE]Related articles

    13.

    Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci.

    Bar K, Wisplinghoff H, Wenzel RP, Bearman GM, Edmond MB.

    BMC Infect Dis. 2006 Sep 26;6:145.PMID: 17002792 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Treatment options for vancomycin-resistant enterococcal infections.

    Linden PK.

    Drugs. 2002;62(3):425-41. Review.PMID: 11827558 [PubMed - indexed for MEDLINE]Related articles

    15.

    Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis.

    DiazGranados CA, Zimmer SM, Klein M, Jernigan JA.

    Clin Infect Dis. 2005 Aug 1;41(3):327-33. Epub 2005 Jun 28.PMID: 16007529 [PubMed - indexed for MEDLINE]Related articles

    16.

    Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia.

    Garbutt JM, Ventrapragada M, Littenberg B, Mundy LM.

    Clin Infect Dis. 2000 Mar;30(3):466-72.PMID: 10722429 [PubMed - indexed for MEDLINE]Related articles

    17.

    Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.

    Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD.

    Clin Infect Dis. 1998 May;26(5):1127-33.PMID: 9597241 [PubMed - indexed for MEDLINE]Related articles

    18.

    Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients.

    Gallagher JC, Perez ME, Marino EA, LoCastro LG, Abrardo LA, MacDougall C.

    Pharmacotherapy. 2009 Jul;29(7):792-9.PMID: 19558253 [PubMed - indexed for MEDLINE]Related articles

    19.

    Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy.

    Forrest GN, Roghmann MC, Toombs LS, Johnson JK, Weekes E, Lincalis DP, Venezia RA.

    Antimicrob Agents Chemother. 2008 Oct;52(10):3558-63. Epub 2008 Jul 28.PMID: 18663022 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia.

    Erlandson KM, Sun J, Iwen PC, Rupp ME.

    Clin Infect Dis. 2008 Jan 1;46(1):30-6.PMID: 18171210 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity